Privacy Policy
Signals Blog

Contributors

Categories

Stacey Johnson

Stacey Johnson is the editor of Signals and a contributor. For 25 years, Stacey has been providing strategic communications counsel to government, corporate, technology and health organizations. She began her career at the CTV Television Network and then moved to Hill & Knowlton Canada where she advised clients in a variety of industries and sectors. Stacey is the Vice President, Communications and Marketing for CCRM, a leader in developing and commercializing regenerative medicine-based technologies and cell and gene therapies. She has a Master's degree in Public Relations. You can follow her on Twitter @msstaceyerin.

Posts by: Stacey


Right Turn: Dateline Mont-Tremblant – TMM 2017

Author: Stacey Johnson, 11/10/17

November 5-8, 2017, Mont-Tremblant, Quebec. The ski resort town of Mont-Tremblant was awash in rain when many of us arrived on Sunday, but the warm and welcoming Fairmont Hotel made up for Nature’s inhospitality. By all measures, the parts we could control were very successful. The 6th annual Till & McCulloch Meetings (TMM), hosted by […]

Right Turn: Considering a career in science or engineering?

Author: Stacey Johnson, 11/03/17

Did you notice surprisingly young-looking employees at your workplace this week? If you’re suffering from that getting old syndrome where that kid at the cash looks 12, but is actually a 27-year-old mother of two, then you may be relieved to know that your eyes weren’t playing tricks on you. Those were 14-year-olds in the […]

Right Turn: Unwrapping bubble boy disease

Author: Stacey Johnson, 10/27/17

Before Jake Gyllenhaal starred in the 2001 comedy Bubble Boy, there was a 1976 version starring John Travolta called The Boy In The Plastic Bubble. Both movies were inspired by the lives of David Vetter, who had severe combined immunodeficiency (SCID), and Ted DeVita, who suffered from severe aplastic amenia. Because of their compromised immune […]

Right Turn: Genes are this season’s hottest trend

Author: Stacey Johnson, 10/20/17

In what feels like back-to-back news, the U.S. Food and Drug Administration (FDA) has approved two gene therapies for cancer. The actual announcements happened seven weeks apart, but for patients, manufacturers, investors and shareholders, it’s like Christmas – over and over again. As you probably know, Novartis’ Kymriah was approved at the end of August […]

Right Turn: This is us

Author: Stacey Johnson, 10/13/17

If you’ve stumbled upon this blog thinking you will be reading about the attractive and talented cast of the popular 2016 TV show on NBC, I suspect you will be very disappointed. While there is video for you below, you will not see any rippling muscles and you don’t need to have any tissues handy […]